Weight shift training and APA feed… for Parkinson's (NCT06598891)
Reduce falls by improving balance
- Trial ID
- NCT06598891
- Official Title
- Effect of Combined PAS Balance Training on Individuals With PD
- Goal
- Reduce falls by improving balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Chang Gung University
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- PD - Parkinson's Disease
- Interventions
- Weight shift training and APA feedback, Paired associative stimulation
Summary For Families
The goal is to improve balance by strengthening the anticipatory postural adjustments that help you shift weight quickly and avoid trips or falls. The approach pairs guided weight-shift training with real-time APA feedback, alongside paired associative stimulation, a noninvasive method that times mild peripheral nerve pulses with magnetic stimulation of the motor cortex to strengthen brain-to-muscle connections and boost learning from the training. Because it is a non-drug intervention, it does not change how levodopa works and is meant to complement your usual medications, not replace them. The study is looking for about 60 adults aged 20 and up with a clinical Parkinson disease diagnosis, excluding people with leg musculoskeletal injuries, osteoporosis, or other peripheral or central nervous system conditions.
Locations
- Chang Gung University, Taoyuan, Taiwan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Weight shift training and APA feedback. The goal is to improve balance by strengthening the anticipatory postural adjustments that help you shift weight quickly and avoid trips or falls. The approach pairs guided weight-shift training with real-time APA feedback, alongside paired associative stimulation, a noninvasive method that times mild peripheral nerve pulses with magnetic stimulation of the motor cortex to strengthen brain-to-muscle connections and boost learning from the training. Because it is a non-drug intervention, it does not change how levodopa works and is meant to complement your usual medications, not replace them. The study is looking for about 60 adults aged 20 and up with a clinical Parkinson disease diagnosis, excluding people with leg musculoskeletal injuries, osteoporosis, or other peripheral or central nervous system conditions.
- Who can participate?
- Participants must be at least 20 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 7 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.